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 Abstract 
     Conventional dendritic cells (cDCs) present α-galactosylceramide (αGC) to invariant 
natural killer T (iNKT) cells through CD1d. Among cDC subsets, CD8+ DCs efficiently 
induce IFN-γ production in iNKT cells. Using fluorescence-labeled αGC, we showed that 
CD8+ DCs incorporated larger amounts of αGC and kept it intact longer than CD8– DCs. 
Histological analyses revealed that Langerin+CD8+ DCs in the splenic marginal zone, which 
was the unique equipment to capture blood-borne antigens, preferably incorporated αGC, and 
the depletion of Langerin+ cells decreased IFN-γ and IL-12 production in response to αGC. 
Furthermore, splenic Langerin+CD8+ DCs expressed more membrane-bound CXCL16, which 
possibly anchored iNKT cells in the marginal zone, than CD8− DCs. Collectively, it is 
suggested that the cellular properties and localization of CD8+ DCs are important for 
stimulation of iNKT cells by αGC. 
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1. Introduction 
     Dendritic cells (DCs) are antigen-presenting cells (APCs) that exist widely in the body 
and survey pathogen invasions [1]. Upon recognition of pathogens, DCs present peptide 
antigens via major histocompatibility complex (MHC) molecules to the T cells. DCs also 
present lipid antigen via nonclassical MHC CD1 to natural killer T cells (NKT cells) [2], 
inducing robust cytokine production. 
     DCs are primarily divided into two populations: conventional DCs (cDCs) and 
plasmacytoid DCs (pDCs) [3]. cDCs are further subdivided into two groups, CD8+ and CD8– 
DCs, by the expression of CD8α [4]. NKT cells are divided into two subsets by the pattern of 
T cell antigen receptor (TCR) expression. Type I NKT cells express invariant TCR, so they 
are designated as invariant NKT (iNKT) cells [5]. iNKT cells recognize marine sponge 
α-galactosylceramide (αGC) on the CD1d molecule of cDCs, inducing antitumor activity via 
the robust production of IFN-γ. During interaction with cDCs, iNKT cells express CD40 
ligand (CD40L), which stimulates cDCs via their CD40, subsequently inducing IL-12 
production from CD8+ DCs. In turn, IL-12 stimulates iNKT cells, resulting in the strong 
production of IFN-γ [6,7] Furthermore, using Langerin-eGFP-diphtheria toxin receptor (DTR) 
mice, depletion of Langerin+ cDCs decreased IL-12 and IFN-γ production after stimulation 
with injection of αGC [8], suggesting that Langerin+CD8+ DCs are involved in IFN-γ 
production of iNKT cells in vivo. However, it is unclear why CD8+ DCs induce higher IFN-γ 
production of iNKT cells than CD8– DCs.  
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     After i.v. injection, antigens in the blood are captured by the splenic marginal zone 
(MZ) cells, causing a rapid immune response [9]. MZ consists of SIGNR1/ER-TR9+ 
macrophages, MZB cells, and cDCs, forming special equipment to sense/capture antigens in 
the blood flowing into the sinus between the MZ and marginal CD169/SER4+ metallophil 
zone. Interestingly, Langerin+CD8+ DCs were observed in the MZ, and iNKT cells migrated 
to the MZ after injection of αGC [10]. 
     Here, we compared αGC uptake and degradation between CD8– and CD8+ DC subsets 
using Cy5-conjugated αGC (Cy5-αGC). We also performed histological analyses to observe 
the uptake of Cy5-αGC in the spleen. Our results suggest that both cellular properties and 
localization of CD8+ DCs enable efficient stimulation of iNKT cells in response to αGC. 
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2. Materials and Methods 
2.1. Mice 
     C57BL/6 (B6) and BALB/c mice were purchased from Japan SLC (Hamamatsu, 
Shizuoka, Japan), Jα18 knock out (KO) mice (B6 background) were provided from Dr. 
Taniguchi (RIKEN RCAI, Yokohama, Japan), and Langerin-diphtheria toxin receptor (DTR) 
mice (B6 background) were provided by Dr. Kabashima (Kyoto University, Kyoto, Japan). 
All mice were housed under specific pathogen-free conditions and used at 7–12 wk of age. All 
experiments were conducted according to our institutional guidelines. 
   
2.2. Reagents and antibodies 
     αGC (Funakoshi Co., Ltd., Tokyo, Japan) was dissolved at 200 µg/ml in 0.5% 
Tween-20 in PBS. Cy5-αGC was provided from Dr. Watarai (The University of Tokyo, Tokyo, 
Japan). Diphtheria toxin (DT) and 30% bovine serum albumin (BSA) solution were purchased 
from Sigma-Aldrich (St Louis, MO). 7-Aminoactinomycin D (7-AAD) was purchased from 
Invitrogen Life Technologies (Carlsbad, CA, USA). RPMI 1640 was purchased from Nissui 
Pharmaceutical Co., Ltd. (Tokyo, Japan). 
     Fluorescein isothiocyanate (FITC)-conjugated anti-CD11c (N418), phycoerythrin 
(PE)-conjugated anti-CD8α (53-6.7) and anti-CD11c mAbs were obtained from eBioscience 
(San Diego, CA, USA). FITC-conjugated anti-CD31 (MEC13.3) and allophycocyanin 
(APC)-conjugated anti-CD8α (53-6.7) mAb were obtained from BD Biosciences (San Diego, 
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CA, USA). Anti-Langerin (L31) and anti-CXCL16 (12-18) [11] mAbs were provided by Dr. 
Steinman (Rockferor University, New York, USA) and Dr. Yonehara (Kyoto University, 
Kyoto, Japan), respectively. Anti-CXCL16 mAb was biotinylated in our laboratory. 
Anti-SER4 mAb was purified from culture supernatant of hybridoma and biotinylated in our 
laboratory. Streptavidin-PE was purchased from BD Biosciences. Cy3-conjugated anti-rat IgG 
was purchased from Jackson ImmunoResearch Europe Ltd. (Cambridgeshire, UK). 
     Hybridomas producing anti-CD16/32 mAb (2.4G2) were purchased from American 
Type Culture Collection (ATCC, Manassas, VA, USA), and culture supernatants were 
produced in our laboratory. 
     MACS microbeads conjugated with anti-mouse CD11c and FITC were purchased from 
Miltenyi Biotec GmbH (Bergisch Gladbach, Germany). 
 
2.3. Cell preparation 
     cDCs were prepared as follows: spleens were treated with 400 U/ml collagenase D 
(Roche, Mannheim, Germany) for 45 min at 37°C, and suspended. Subsequently, low density 
cells were obtained by centrifugation at 800 × g for 30 min using 30% BSA. CD11c+ cells 
were purified from the cells using anti-CD11c microbeads following the manufacturer’s 
protocol. To check depletion of CD8+ DCs by DT treatment, whole splenocytes after the 
collagenase digestion were subjected to flow cytometry. For measurement of CXCL16 on the 
cell surface, the spleen was dispersed in 5 mM EDTA in PBS and whole splenocytes were 
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analyzed using flow cytometry. 
 
2.4. Flow cytometry of cell populations and Cy5-αGC uptake 
     Fc receptors on cells were blocked with anti-CD16/32 mAb in staining buffer for 30 
min on ice, and stained for 30 min on ice with mAbs. Data were collected on FACSCalibur and 
were analyzed with FlowJo (TreeStar, Ashland, OR). Net MFI was obtained by subtraction of 
the isotype mAb MFI from that of specific mAb. 
     For the in vivo assay of Cy5-αGC uptake, Jα18 KO mice were injected i.v. with 5 µg 
Cy5-αGC in 200 µL PBS. At various time points, splenocytes were stained with 
anti-CD11c-FITC, anti-CD8-PE, and Cy5-αGC incorporation of cDCs was measured by flow 
cytometry. The net uptake of Cy5-αGC was calculated by subtracting MFI of Cy5 
fluorescence of untreated mouse cDCs from that of treated mouse cDCs. 
     For the in vitro assay of Cy5-αGC uptake, cDCs stained with anti-CD11c-FITC and 
anti-CD8-PE were cultured in the presence of graded doses of Cy5-αGC for 1 h, or of 100 
ng/mL αGC for various time points. After incubation, Cy5-fluorescence intensity was 
measured gating on CD11c+CD8+ and CD11c+CD8– by flow cytometry. Autofluorescence 
intensity and background binding of Cy5-αGC by cDCs were calculated by subtraction of 
fluorescence intensity (MFI) of cDCs cultured with Cy5-αGC at 4ºC from that of cDCs 
cultured at 37ºC. In pulse and chase experiments, net MFI was calculated by subtraction of 
autofluorescence intensity of cDCs from MFI of cDCs cultured with Cy5-αGC at 37ºC. 
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The % reduction was calculated using the following formula: [MFI of Cy5-αGC at the time 
point / that at the initial time point × 100]. In some cases, NH4Cl (20 mM) was added in the 
culture. 
 
2.5. Cytokine assay 
     To observe cytokines in sera, mice were injected i.v. with 5 µg αGC. After 2 or 4 h, 
blood was collected. After clotting, IL-12p70, IL-4, and IFN-γ in the sera were assessed by a 
cytometric bead array (CBA, BD Bioscience). In some cases, Langerin-DTR mice or B6 mice 




     Spleens were frozen in Tissue-Tek OCT-compound (SAKURA SEIKI Co., Ltd, Tokyo, 
Japan) at -20 ºC. Cryostat sections (10 µm in thickness) were dried, fixed in acetone for 10 min 
and then dried again. After Fc blocking with anti-CD16/32 mAb, sections were stained for 1 h 
with antibodies in staining buffer (1% FCS, 0.02% NaN3, 5 mM EDTA in PBS). Images were 
obtained with a fluorescence microscope BX51 (OLYMPUS, Tokyo, Japan). In some cases, 
mice were pulsed i.v. with Cy5-αGC, and spleen sections were prepared after 15 min. To 
observe the distribution of Langerin+ DCs in the spleen, BALB/c mice were used, because of 
the low expression of Langerin in B6 mice. 
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2.7. Statistical analysis 
     Data are expressed as the mean ± SD of triplicate cultures or three mice in each group. 
Statistical significances were determined by the Student’s-t test. Differences were considered 
significant for p values < 0.05. All experiments were performed at least two times and 
representative results are shown. 
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3. Results and Discussion 
3.1. CD8+ DCs effectively uptake more Cy-5-αGC than CD8− DCs in vivo. 
     We first confirmed previous results showing higher presentations of αGC and induction 
of IFN-γ production from iNKT cells by CD8+ DCs in comparison with CD8− DCs. After i.v. 
injection, αGC presentation on cDC subsets was measured at various time points 
(Supplementary Fig. 1A) using mAb specific to the αGC/CD1d complex [12], indicating that 
CD8+ DCs expressed larger amounts of the αGC/CD1d complex than CD8− DCs as reported 
previously [13]. Consistently, CD8+ DCs upon loading with αGC in vivo induced higher 
IFN-γ after co-culture with naïve iNKT cells (Supplementary Fig. 1B). For IFN-γ production, 
IL-12 produced by CD8+ DCs was indispensable (Supplementary Fig. 1C, D). To acquire the 
IFN-γ inducing activity via IL-12 production, cDCs require interaction in vivo with iNKT 
cells during αGC presentation (Supplementary Fig. 1E) as reported previously [6]. 
     Then, we compared αGC uptake using its fluorescent derivative between CD8+ and 
CD8– DCs in vivo. For precise comparisons, we used Jα18 KO mice that lacked iNKT cells 
[14], as iNKT cells possibly killed mature cDCs that presented αGC. The mice were injected 
with Cy5-αGC, and fluorescence of cDC subsets was checked at various time points (Fig. 1), 
indicating that CD8+ DCs incorporated larger amounts of Cy5-αGC than CD8− DCs at all 
time points. This result suggests that CD8+ DCs uptake αGC more efficiently than CD8− DCs 
in vivo, leading to the robust induction of IFN-γ from iNKT cells.  
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3.2. CD8+ DCs phagocytose more Cy5-αGC and keep it intact longer than CD8− DCs in 
vitro. 
     We then observed the uptake of Cy5-αGC in CD8+ and CD8− DCs in vitro. Purified 
CD8+ and CD8− DCs were co-cultured in vitro with Cy5-αGC to observe its incorporation. 
Consistent with the in vivo results at all concentrations of Cy5-αGC (Fig. 2A) and incubation 
time points (Fig. 2B) tested, CD8+ DCs showed higher Cy5 fluorescence intensity than CD8− 
DCs. Besides, like protein antigens, αGC is loaded onto CD1d in endosomes/lysosomes [2], 
and endosome pH in CD8+ and CD8− DCs is about 7 and 6, respectively [15], suggesting that 
stability of αGC in endosomes/lysosomes is different between them. To clarify this, we 
treated cDCs with NH4Cl to inhibit endosome/lysosome acidification. When NH4Cl was 
added in culture, CD8+ DCs did not change the intensity of Cy5 fluoresce (Fig. 2C). However, 
CD8– DCs increased Cy5 fluorescence, but it was still lower than that of CD8+ DCs. We 
determined that Cy5 fluorescence was not affected from pH 7 to 4.5 (data not shown). These 
results suggest that CD8+ DCs take up more Cy5-αGC than CD8− DCs, and that Cy5-αGC is 
degraded by the low pH of endosomes in CD8− DCs. To further clarify this, cDCs were 
pulsed with Cy5-αGC for 30 min, and a change of fluorescence intensity was observed (Fig. 
2D). The results indicated that CD8– DCs lost Cy5 fluorescence faster than CD8+ DCs. We 
then confirmed the presentation of the αGC/CD1d complex on the DCs using flow cytometry. 
The results indicated that CD8+ DCs presented larger amounts of αGC/CD1d complex than 
CD8− DCs at the concentrations we tested (Figs. 2E, F). 
Ushida M. et al. 
 13 
     When endosomal pH in DCs is up-regulated, the loading activity of αGC by CD1d 
decreases [2,16], suggesting lower efficiency of αGC presentation of CD8+ DCs than that of 
CD8− DCs. However, CD8+ DCs presented larger amounts of αGC than CD8− DCs in vivo 
and in vitro. Therefore, CD8+ DCs seem to accumulate higher amounts of αGC than CD8− 
DCs, overcoming their low efficiency of αGC loading in high endosomal pH. Collectively, 
CD8+ DCs effectively incorporate αGC and keep it intact, leading to the higher αGC/CD1d 
presentation compared to CD8− DCs. 
 
3.3. Langerin+CD8+ DCs in MZ capture αGC, and are crucial for cytokine production from 
iNKT cells. 
     Langerin is one of the specific markers of splenic CD8+ DCs (Fig. 3A). 
Immunostaining with anti-Langerin mAb revealed that CD8+ DCs were primarily localized at 
the MZ, outer layer of SER4+ marginal metallophil, and bridging area (Fig. 3B). After i.v. 
injection, Cy5-αGC was observed in CD11c positive cells of MZ (Fig. 3C) and CD31+ 
endothelial cells of blood vessels (Fig. 3D). A weak Cy5 signal was also detected in the B cell 
area (Fig. 3C). Including the results above (Supplementary Fig. 1 and Fig. 1), these findings 
suggest that Langerin+CD8+ DCs are strategically located in MZ, especially adapted for 
sensing blood-borne antigens, and preferentially capture αGC in the spleen. 
     To define the relevance of capturing and presentation of αGC by the Langerin+CD8+ 
DCs, Langerin-DTR mice were treated with DT and injected i.v. with αGC. As shown in Fig. 
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3E, DT treatment effectively decreased CD8+ DCs in Langerin-DTR mice. In the control 
(PBS) treatment, Langerin-DTR mice produced comparative level of IL-12, but lower levels 
of IFN-γ and IL-4, compared to WT mice after αGC administration (Fig. 3F). The reason for 
such low levels of IFN-γ and IL-4 is not clear. Nevertheless, in Langerin-DTR mice, DT 
treatment significantly decreased amounts of IFN-γ and IL-12, not IL-4, as previously 
reported by Farrand et al. [8]. Therefore, it is suggested that Langerin+CD8+ DCs in MZ 
capture αGC and lead to in vivo IFN-γ production by iNKT cells. 
 
3.4. CD8+ DCs express larger amounts of membrane-bound CXCL16 than CD8− DCs. 
     CXCL16 is a ligand of CXCR6 expressed in iNKT cells [17]. Although no difference of 
iNKT cell numbers was observed between WT and CXCR6-lacking mouse spleens, after 
treatment with αGC, IFN-γ-producing iNKT cells decreased significantly in the deficient 
mice [18]. It has also been suggested that membrane-bound CXCL16 on DCs mediates 
interactions with CXCR6 expressed on iNKT cells, leading to their adhesion/anchoring and 
full activation of iNKT cells [11,19]. However, the expression of membrane-bound CXCL16 
on cDC subsets is unknown. Before stimulation with αGC, CD8+ DCs expressed higher 
amounts of membrane-bound CXCL16 than CD8– DCs (Fig. 4). Four hours after αGC 
injection, the expression by CD8+ DCs did not change. CD8– DCs expressed small amounts of 
membrane-bound CXCL16 regardless of αGC injection. King et al. reported that iNKT cells 
were widely localized in the spleen in the resting state and subsequently migrate into MZ after 
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treatment with αGC [10]. Therefore, it is possible that the membrane-bound CXCL16 
adherers/anchors facilitated the migration of iNKT cells to CD8+ DCs in MZ after αGC 
injection. The other possibility is that anchoring of small numbers of naïve iNKT cells in MZ 
at a steady state leads to the effective recognition of αGC presented by CD8+ DCs during the 
first step of the immune response. As mentioned above (Supplementary Fig. 1E), iNKT cells 
are indispensable for acquiring iNKT cell activation by CD8+ DCs in vivo. Therefore, in both 
cases, it seems that efficient adhesion of CD8+ DCs with iNKT cells via CXCL16–CXCR6 




     In cDC subsets, CD8+ DCs uptake αGC effectively compared with CD8− DCs in vivo 
and in vitro. In addition, αGC is more stable in CD8+ DCs than in CD8− DCs. It is possible 
that these two properties of CD8+ DCs result in their efficient accumulation and presentation 
of αGC. Furthermore, CD8+ DCs strategically localize in the MZ, which is specialized in 
capturing blood-borne antigens, and preferentially uptake αGC injected i.v. Furthermore, 
CD8+ DCs in the spleen express higher levels of membrane-bound CXCL16 than CD8− DCs, 
possibly enhancing activation of iNKT cells. These cellular properties and localization of 
CD8+ DCs seem to enable the robust induction of IFN-γ from iNKT cells in vivo. 
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Figure legends 
Fig. 1. CD8+ DCs took up more αGC than CD8– DCs in vivo. 
Jα18 KO mice (n = 4) were injected i.v. with 5 µg of Cy5-αGC. At the time points indicated, 
Cy5 fluorescence of splenic CD8+ and CD8– DCs was measured by flow cytometry. 
 
Fig. 2. CD8+ DCs were superior in αGC-uptake and its retention to CD8– DCs in vitro. 
(A) Purified DCs were cultured with the indicated doses of Cy5-αGC. After 1 h, Cy5 
fluorescence of CD8+ and CD8– DCs was measured by flow cytometry. (B) Purified DCs 
were cultured with 100 ng/mL Cy5-αGC for the time points indicated, and Cy5 fluorescence 
was analyzed. (C) NH4Cl was added to the culture, and Cy5 fluorescence was analyzed as in 
(B). (D) After culture with 100 ng/mL Cy5-αGC for 30 min, purified cDCs were cultured, and 
change of MFI of Cy5 fluorescence at the various time points was analyzed. (E) Low-density 
spleen cells were cultured with or without 100 ng/mL non-labeled-αGC for 4 h, followed by 
staining with anti-CD11c-FITC, anti-CD8-APC, PE-anti-αGC/CD1d complex, and 7-AAD. 
7-AAD– live cells were analyzed. Solid lines and shadows indicate intensity of 
anti-αGC/CD1d complex and isotype control mAb, respectively. (F) Low-density cells were 
cultured with graded doses of αGC for 4 h, and level of αGC/CD1d complex was analyzed as 
in (E). *p < 0.01 by Student’s t-test. 
 
Fig. 3. DC8+ DCs in the splenic marginal zone took up Cy5-αGC. 
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(A) Expression of Langerin on cDC subsets from BALB/c naïve mice was analyzed. Solid 
lines and shadows indicate staining of anti-Langerin and isotype control mAb, 
respectively. (B) BALB/c mouse spleen section was stained for CD11c (green), Langerin 
(red), and SER4 (white). T: T area; B: B area; MZ: marginal zone; CA: central arteriole. 
Bar indicates 100 µm. (C, D) After 15 min of injection of Cy5-αGC (red), the section was 
stained for CD11c (green) and SER4 (white) (C), or CD31 (white) (D). Bar indicates 100 
µm. (E) CD8+ DCs in spleen of WT and Langerin-DTR mice (B6 background) were 
analyzed after control (PBS) or DT treatment by flow cytometry. Numbers indicate 
percentages of CD8+ DCs in 7AAD- splenocytes. (n = 3) (F) W 
(B) T mice (n = 6) and Langerin-DTR mice (n = 7) treated with PBS or DT were injected i.v. 
with 5 µg of αGC and sera were collected at 2 h (IL-4) and 4 h (IFN-γ, IL-12). Cytokines 
were measured by cytometric bead array (CBA). *p < 0.01 by Student’s t-test. N. S.: not 
significant. 
 
Fig. 4. CD8+ DCs expressed larger amounts of membrane-bound CXCL16 than CD8− DCs.  
Expression of CXCL16 on cDC subsets from B6 mice was analyzed 4 h after i.v. injection 
with 5 µg of αGC or vehicle by flow cytometry. Solid lines and shadows indicate staining of 
anti-CXCL16 and isotype control mAb, respectively (left panels). The results from three mice 
are depicted (right panel). N. S.: not significant. 
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1) We saw the fate of fluorescent α-galactosylceramide (Cy5-αGC) in vivo and in vitro. 
2) CD8+ dendritic cells (DCs) captured more αGC than CD8− DCs in vivo and in vitro. 
3) Cy5-αGC was more stable in CD8+ DCs than in CD8− DCs. 
4) Langerin+CD8+ DCs in the splenic marginal zone incorporated Cy5-αGC. 
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Supplementary information 
1. Supplementary Materials and Methods 
1.1. Reagents and antibodies 
     Fluorescein isothiocyanate (FITC)-conjugated anti-CD11c (N418), phycoerythrin (PE)-
conjugated anti-CD8α (53-6.7), and anti-αGC/CD1d (L363) mAb were obtained from 
eBioscience (San Diego, CA, USA). FITC-conjugated anti-CD19 (1D3), PE-conjugated anti-
mouse IgG1 (A85-1), and allophycocyanin (APC)-conjugated anti-CD8α (53-6.7) mAb were 
obtained from BD Biosciences (San Diego, CA, USA). Dimer X (mouse CD1d-Ig) was 
purchased from BD Biosciences. Neutralizing anti-IL-12 mAb was purchased from Biosource 
international (Camarillo, CA, USA). 
     Hybridomas producing anti-MHC class II (M5/14.15.2), anti-CD8α (53-6.72), anti-
CD62L (Mel-14), anti-CD11b (M1/70), and anti-B220 (RA3-6B2.1) were purchased from 
ATCC, and culture supernatants were produced in our laboratory. 
     MACS microbeads conjugated with anti-mouse CD11c was from Miltenyi Biotec GmbH 
and Dynabeads conjugated with sheep anti-rat IgG from Invitrogen Life Technologies. 
 
1.2. Cell preparation, stimulation, and culture 
     Purified cDCs subsets and iNKT cells were prepared as described previously [1]. Briefly, 
for cDC subsets preparation, purified CD11c+ cells using anti-CD11c microbeads were stained 
with anti-CD11c-FITC and anti-CD8-PE, and sorted into CD8+ and CD8− DC with FACS 
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VantageSE (BD Biosciences). 
     For iNKT cell preparation, splenocytes were depleted with anti-MHC II, CD8, CD62L, 
CD11b, CD16/32, and CD45R mAbs using Dynabeads, and dead cells were further removed 
with Dead Cell Removal kit (Miltenyi Biotec) in accordance with the manufacturer’s protocol. 
The cells were stained with anti-CD19-FITC, αGC/Dimer X and anti-mouse IgG1-PE, and then 
CD19−αGC/Dimer X+ cells were sorted with FACS VantageSE. 
     For in vivo αGC loading experiments, cDCs were sorted after 2 h of i.v. injection of 5 µg 
αGC. Various numbers of sorted cDCs were co-cultured with iNKT cells (1 × 104 cells/well) 
for 72 h, and IL-12p70, IL-4, and IFN-γ in culture supernatant were measured by ELISA. In 




[1] Iyoda T, Ushida M, Kimura Y, Minamino K, Hayuka A, Yokohata S, et al. Invariant 
NKT cell anergy is induced by a strong TCR-mediated signal plus co-stimulation, Int. 
Immunol. 22 (2010) 905-913. 
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2. Supplementary Figure 
 
 
Supplementary Fig. 1. CD8+ DCs presented αGC/CD1d and induced IFN-γ production of iNKT 
cells more efficiently than CD8– DCs. 
(A) WT mice (n = 3) were injected i.v. with 5 µg of αGC. At the times points indicated, 
αGC/CD1d complex expression on cDC subsets was measured by a flow cytometer. (B) Two 
hours after i.v. injection of 5 µg of αGC, CD8+ DCs and CD8– DCs were sorted and co-cultured 
with naïve spleen iNKT cells for 72 h. IFN-γ production was measured by ELISA. (C) IL-12 in 
supernatant culture as in (B) was measured. (D) IFN-γ in supernatant culture as in (B) with 
neutralizing anti-IL-12p40 mAb was measured. (E) Two hours after i.v. injection of 5 µg of 
αGC in WT and Jα18 KO mice, splenic CD8+ and CD8− DCs were co-cultured with iNKT cells 
for 72 h. IFN-γ production was measured by ELISA. *p < 0.01 by Student’s t-test. 
